Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome
PaperCitations, authors & open-access status
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 158 citations, 2020 year and hybrid oa status.
158
Citations
2020
Year
hybrid
OA Status